Recall Atlas
Drugs & medicalClass II

Curium US, LLC recalls Kit for the Preparation of Technetium Tc 99m Sestamibi Injection, Each Kit contains: 30 sterile and non-pyrogenic reaction vials each…

Lack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product

Read the official notice →
Date
2025-01-01
Country
United States
Brand
Curium US, LLC
Product
Kit for the Preparation of Technetium Tc 99m Sestamibi Injection, Each Kit contains: 30 sterile and non-pyrogenic reaction vials each…
Classification
Class II
Units
Nationwide USA and Canada.
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in the United States

  1. 2025-01-01
  2. US
    Drugs & medicalClass I

    Nova Biomedical Corporation recalls StatStrip Glucose Hospital Meter System. Model/Catalog Number: 63685. Prescription use blood glucose meter for near-patient testing.

    A software bug within the Gen 2 StatStrip Hospital Meter firmware leads to transmission of erroneous glucose patient test results to a healthcare institution's data management system (DMS) at healthcare sites using…

    FDA · DeviceNova Biomedical CorporationDistribution US Nationwide including Puerto Rico, Germany, Italy, Israel,…Official notice →
  3. US
    Drugs & medicalClass II

    MXBBB recalls UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323

    cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product…

    FDA · DrugMXBBBProduct was sold via Amazon Marketplace.Official notice →
  4. US
    Drugs & medicalClass II

    RemedyRepack Inc. recalls Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC 70518-0937-03), Rx…

    CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.

    FDA · DrugRemedyRepack Inc.Nationwide in the USOfficial notice →
  5. US
    Drugs & medicalClass II

    PD-Rx Pharmaceuticals, Inc. recalls DULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharmaceuticals Inc, Oklahoma City, OK 73127, NDC: 43063-877-90

    CGMP Deviations: the presence of a Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Duloxetine above the interim acceptable intake limit

    FDA · DrugPD-Rx Pharmaceuticals, Inc.Distributed within US: FL, MS, WIOfficial notice →
  6. US
    Drugs & medicalClass II

    Breckenridge Pharmaceutical, Inc recalls Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, 90-count bottles (NDC 51991-747-90) Mfr. by: Towa Pharmaceutical…

    CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.

    FDA · DrugBreckenridge Pharmaceutical, IncNationwide in the USOfficial notice →
  7. US
    Drugs & medicalClass II

    Glenmark Pharmaceuticals Inc., USA recalls chlorproMAZINE Hydrochloride Tablets, USP, 10mg, 100-count bottle, RX only, Manufactured for: Glenmark Pharmaceuticals Inc.,…

    CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.

    FDA · DrugGlenmark Pharmaceuticals Inc., USAUSA NationwideOfficial notice →
See all drugs & medical recalls →